A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
Clinical trial NCT01130623 · WITHDRAWN
Trial details
- NCT number
- NCT01130623
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-10
- Primary completion
- 2011-11-18
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.